Elawyers Elawyers
Washington| Change

Petr Bocek v. JGA Associates, LLC, 14-1208 (2015)

Court: Court of Appeals for the Fourth Circuit Number: 14-1208 Visitors: 100
Filed: Jun. 18, 2015
Latest Update: Mar. 02, 2020
Summary: UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 14-1208 PETR BOCEK, M.D., PHD, Plaintiff - Appellant, v. JGA ASSOCIATES, LLC; JOSEPH P. AMATO, Defendants – Appellees, and ALLERGY CARE CENTERS, VIRGINIA, INC.; A2 MEDICAL GROUP, INC., Defendant, LENA BOCEK, Movant. Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Claude M. Hilton, Senior District Judge. (1:11-cv-00546-CMH-JFA) Argued: March 24, 2015 Decided: June 18, 2015 Befor
More
                              UNPUBLISHED

                   UNITED STATES COURT OF APPEALS
                       FOR THE FOURTH CIRCUIT


                              No. 14-1208


PETR BOCEK, M.D., PHD,

                 Plaintiff - Appellant,

           v.

JGA ASSOCIATES, LLC; JOSEPH P. AMATO,

                 Defendants – Appellees,

and

ALLERGY   CARE   CENTERS,   VIRGINIA,   INC.;   A2   MEDICAL   GROUP,
INC.,

                 Defendant,

LENA BOCEK,

                 Movant.



Appeal from the United States District Court for the Eastern
District of Virginia, at Alexandria.    Claude M. Hilton, Senior
District Judge. (1:11-cv-00546-CMH-JFA)


Argued:   March 24, 2015                        Decided:   June 18, 2015


Before TRAXLER, Chief Judge, and WILKINSON and NIEMEYER, Circuit
Judges.


Reversed and remanded by unpublished opinion.       Chief           Judge
Traxler wrote the opinion in which Judge Niemeyer joined.           Judge
Wilkinson wrote a separate concurring opinion.
ARGUED: S. Micah Salb, LIPPMAN, SEMSKER & SALB, LLC, Bethesda,
Maryland, for Appellant.     Kristen Michelle Kanaskie, SHER,
CUMMINGS AND ELLIS, PLLC, Arlington, Virginia, for Appellees.
ON BRIEF: Mary E. Kuntz, Ph.D., LIPPMAN, SEMSKER & SALB, LLC,
Bethesda, Maryland, for Appellant.    David E. Sher, Mark D.
Cummings, SHER, CUMMINGS AND ELLIS, PLLC, Arlington, Virginia,
for Appellees.


Unpublished opinions are not binding precedent in this circuit.




                                2
TRAXLER, Chief Judge:

      Petr Bocek brought this action against business consultant

Joseph Amato and two companies associated with Amato after the

defendants purchased a medical practice for themselves rather

than for Bocek.             Following a bench trial, the district court

granted judgment in favor of the defendants, and Bocek appeals.

We reverse and remand for a new trial.

                                                  I.

      Plaintiff Petr Bocek is a medical doctor specializing in

the   treatment        of   allergies.             Defendant        Joseph      Amato    is    the

manager    and    sole      member      of   defendant         JGA    Associates,        LLC,    a

business consulting firm.

      Bocek contacted Amato seeking assistance with the formation

and   financing        of   a    new    allergy         care     medical       practice.        On

November    10,    2010,        the    parties         entered    into     a   contract       (the

“Consulting Agreement”) through which JGA agreed “to review and

report    on     the    feasibility          of       the   proposed     allergy        medicine

practice and prepare a business proposal for funding a start-up

medical    practice”        and    “render         such     other    services      as    may    be

agreed upon by [Bocek] and [JGA].”                          J.A. 221.           The agreement

provided that JGA would have “the right to act [as] an agent

representing [Bocek] to Interested Parties during the term of

this Agreement.”            J.A. 221.         (Amato clarified that “Interested

Parties” in that context referred to prospective lenders.)                                     The

                                                  3
agreement also provided that JGA would be compensated through

“development fees” (hourly billing for consulting services) and

a “completion fee” of two percent of the face amount of any

business loan that JGA arranged.

      On   November     15,   five    days       after       signing    the   Consulting

Agreement, Bocek asked Amato about the feasibility of buying an

existing medical practice rather than starting a new practice.

Bocek told Amato that Allergy Care Centers (“ACC”), where Bocek

had   previously      worked,      was   being         offered    for    sale    by   the

administrator of the estate of ACC’s owner, who had died two

years earlier.        Bocek noted that the Estate was burdened with

taxes and that the practice was profitable, and he suggested

that reductions in offices and staff could make it even more so.

Amato responded positively, explaining that “[t]he acquisition

of an existing operating practice is always more attractive if

the price and the historic financial performance make sense.”

J.A. 225.

      Bocek informed Amato in an email on December 1 that ACC was

currently    owned    by    the    estate       of     Charles   M.     Valentine     (the

“Estate”)    and   that     Peter    Klenk       was    the    lawyer    handling     the

Estate.     The email stated that Bocek was unsure how to confirm

that ACC was for sale and, if it was, what price the estate was

asking,    but   that      Bocek    would       want    an    independent       appraisal

regardless.      Bocek also told Amato that his acquisition of ACC

                                            4
might be complicated because he had been fired from ACC and was

in the process of negotiating a severance package, and Bocek

asked   Amato    to     pursue    the    purchase       of    ACC   without        revealing

Bocek’s identity as the buyer.

       By that afternoon, Amato had communicated with Klenk and

informed Bocek that ACC was in fact on the market.                                Amato told

Bocek that he would assemble a checklist of information that he

would need to review and he would include any special requests

from Bocek when he communicated again with Klenk.                                 Amato also

told Bocek that the purchase would “be considered an asset-only

transaction.”         J.A. 237.         On December 15, JGA sent Bocek an

email containing a historical financial analysis, a preliminary

business valuation report, as well as an excel document he had

created regarding ACC’s accounting summaries.                         Bocek spoke to

Amato the next day regarding these documents.

       The evidence regarding the conversations between Bocek and

Amato is somewhat in dispute.                    Nevertheless, it appears that

Bocek was concerned that he might not have the cash available to

make a sufficient down payment.                  Amato testified that for that

reason, and because Bocek wanted to keep his name out of the

transaction      with      the   Estate,    he     was       exploring    a       number   of

different   ways      to    structure      the    deal,       including       a    mezzanine

lending structure.           Under that structure, a lender would have

some    rights   to     convert    its     loan    to    an     ownership         or   equity

                                            5
interest in the practice if the loan were not timely repaid in

full.

     On December 23, Amato sent Bocek an email informing him

that JGA had “put in a closed bid to purchase ACC on Monday . .

. to attempt to secure a position in the possible acquisition of

ACC,” that the law firm Klenk had hired was considering the

offer, and that they “could begin a formal due diligence process

with ACC.”     J.A. 265.        Amato added that “there are still many

questions    both     our    firm    and       you    may    have     regarding    the

transaction.”       J.A. 265.       For that reason, Amato stated that he

“intend[ed] to move forward based on a few specific parameters.”

J.A. 265.    As is relevant here, Amato stated that “[JGA] (or an

alternate    holding    company)      intends        to   initially    purchase     the

practice with the direct intention of selling the practice (or

the holding company) to” Bocek.            J.A. 265.

     In   response,     on   December          27   Bocek   sent    Amato   an    email

confirming that he understood that he would “be the owner of ACC

from the day of purchase.”             J.A. 267.            However, he expressed

uncertainty regarding how the purchase would be structured and

who would provide the down payment.                  The next day Amato emailed

Bocek, once again confirming that JGA’s goal was to make Bocek

the owner of ACC from the day of purchase.                   In the end, however,

although Amato and Bocek discussed several options regarding how

the deal would be structured, they never resolved that issue.

                                           6
     On January 22, 2011, Amato sent Bocek an invoice for his

services.      The    invoice   reflected         Bocek’s    prior    payment    of

$3,800.00 and sought an additional $4,574.40 “for expanded hours

and third-party costs associated with the project development

and acquisition negotiations for the purchase of the Allergy

Care Center business operation on behalf of JGA Associates and

Dr. Petr Bocek.”       J.A. 291.     On January 31, Bocek sent an email

to JGA indicating that his lawyers would be in contact with JGA

to put in place a new written contract since the Consulting

Agreement was created under the assumption that Bocek would be

developing and obtaining financing for a new practice rather

than acquiring an existing one.

     On February 3, Amato sent the Estate a Letter of Intent

(“LOI”)    through    which   “JGA   Associates,      LLC,    or     its   assigns”

offered to purchase ACC’s assets for $1,000,000.                   J.A. 301.    The

LOI obligated the parties to negotiate in good faith, but it was

otherwise    not     binding;   until       the   execution    of     a    mutually

agreeable asset purchase agreement, either side could walk away

from the transaction without penalty.                The Estate accepted the

offer and returned an executed copy of the LOI to Amato late in

the afternoon on February 8.

     Earlier that same day (February 8), Amato had visited one

of the ACC offices to meet with Terri Crook, ACC’s practice

manager.     During the meeting, Crook told Amato that Bocek had

                                        7
been fired after he sexually harassed employees and used another

doctor’s prescription pad to forge prescriptions for himself.

This was the first Amato had heard of these issues; although

Bocek    had   told   Amato     that    he       had   been    fired,    he   had    never

provided any details about what happened, and Amato had never

asked.       After meeting with Crook, Amato stalled and put off

Bocek’s     various     inquiries      until      he   could    verify    what      he    had

learned.

       On    February     15,    the     Estate        filed     a   petition        in    a

Pennsylvania “Orphan’s Court” seeking approval for the sale of

ACC.     Bocek was then unaware that the sale was moving forward −

Amato had not informed Bocek that he submitted the LOI to the

Estate on February 3 or that the LOI had been accepted.

       On February 17, after reviewing documents that confirmed

Crook’s information, Amato sent a letter notifying Bocek of his

intent to terminate their contractual relationship in 10 days,

in accordance with the terms of the Consulting Agreement.                            Amato

explained the termination in general terms, stating that during

the due-diligence process, “it became apparent . . . that your

involvement in any potential transaction would . . . sour the

deal.       It also became evident that we could not move forward

with your participation in any potential transaction without the

possibility of serious repercussions thereafter.”                       J.A. 317.



                                             8
     Counsel for Bocek responded on February 22.                                 Among other

things,   counsel      noted       that    Amato,         as    Bocek’s     agent,      had   a

continuing duty of loyalty to Bocek and that Amato would be

breaching his contractual and fiduciary duties “if [he] were to

turn the acquisition of ACC into a deal which is of benefit to

[him].”     J.A. 629.      Nevertheless, on March 2, Amato incorporated

a new company, A2 Medical Group, Inc. (“A2”), to serve as the

purchaser of ACC’s assets.                Brian August, Jeffrey Renzulli, and

Amato were named as directors of A2, with Amato and Brian August

each owning 49 percent of A2’s shares and Carolyn August owning

two percent.        JGA at some point assigned its interests in the

transaction    to    A2,     and    the    Estate         and   A2   executed      an   asset

purchase agreement on May 13.                       Ten days later, the Orphan’s

Court approved the sale, and the sale closed on June 22.

     Bocek testified that after Amato terminated the agreement,

Bocek   simply      wanted    Amato       to       give    Bocek     the    due    diligence

documents and analysis that Amato had developed for him, and

that Bocek was prepared to purchase ACC himself.                                 Bocek never

made an offer, however.

     After    unsuccessfully          seeking         an       injunction    to     prohibit

Amato and JGA from buying ACC, Bocek filed an Amended Complaint

asserting four causes of action against Amato, JGA, and A2:                                (1)

fraudulent    conveyance       and    constructive              trust;     (2)    breach      of

fiduciary    duties;    (3)    breach          of   contract;        and   (4)    breach      of

                                               9
fiduciary duties as joint venturers.               The district court granted

summary judgment in favor of the defendants and dismissed the

case.

      It is the breach-of-fiduciary-duties claim that is at issue

in this appeal.           In his Amended Complaint, Bocek alleged that

Amato and JGA, as his agents, owed him various fiduciary duties,

including a duty of loyalty.               Bocek alleged that he brought the

ACC   business      opportunity     to    JGA   during   the     existence   of   the

agency relation, and that JGA was acting on behalf of Bocek when

it    began     negotiating    with       the   Estate    and      conducting     due

diligence.         Bocek alleged that the defendants breached their

fiduciary duties by, inter alia, using information obtained on

Bocek’s behalf to pursue the acquisition of ACC for themselves,

refusing to return the due diligence materials to him, and, of

course, buying ACC for their own benefit rather than for Bocek's

benefit.

      Regarding this claim, the district court held that because

the     fiduciary     duties   at     issue     arose     from     the   Consulting

Agreement, not independently of it, Bocek was precluded as a

matter        of    law     from         recovering      in      tort    for      the

breach.    See Augusta Mut. Ins. Co. v. Mason, 
645 S.E.2d 290
, 293

(Va. 2007) (where single act can support a claim for breach of

contract and a claim for breach of a duty arising in tort, “in

order to recover in tort, the duty tortiously or negligently

                                           10
breached must be a common law duty, not one existing between the

parties solely by virtue of the contract” (internal quotation

marks omitted)); see also Station #2, LLC v. Lynch, 
695 S.E.2d 537
, 540 (Va. 2010) (“[A]n omission or non-performance of a duty

may sound both in contract and in tort, but only where the

omission     or   non-performance      of    the    contractual        duty     also

violates a common law duty.”).

      On   appeal,   we   affirmed    regarding     the    breach-of-contract,

fraudulent-conveyance, and joint-venture claims.                   See Bocek v.

JGA   Assocs.,    LLC,    537   F.   App’x   169,   179     (4th      Cir.    2013).

However,     we   reversed      concerning   the    claim       for    breach     of

fiduciary duties, with Chief Judge Traxler and Judge Niemeyer

articulating slightly differing rationales for their decisions,

and   with   Judge    Wilkinson      dissenting.          See   
id. at 176-77
(Traxler, C.J.); 
id. at 179-80
(Niemeyer, J., concurring in part

and concurring in the judgment); 
id. at 180-82
(Wilkinson, J.,

concurring and dissenting).

      Chief Judge Traxler observed that

      Bocek alleged that he brought the ACC business
      opportunity to JGA during the existence of the agency
      relation, and that JGA was acting on behalf of Bocek
      when it began negotiating with the Estate and
      conducting due diligence.     Bocek alleged that the
      defendants breached their fiduciary duties by, inter
      alia, using information obtained on Bocek’s behalf to
      pursue the acquisition of ACC for themselves, refusing
      to return the due diligence materials to him, and, of
      course, buying ACC for their own benefit rather than
      for Bocek’s benefit.

                                       11

Id. at 176
(Traxler, C.J.).            Chief Judge Traxler reasoned that

if    these    factual     allegations       were     proven   at    trial,    the

defendants’ conduct would constitute a clear breach of fiduciary

duty.     See 
id. (Traxler, C.J.).
           Chief Judge Traxler concluded

that Augusta Mutual, on which the district court had relied, did

not   bar     recovery    on   a   breach-of-fiduciary-duty         theory.    He

further concluded that even if the fiduciary duty arose from

contract, “recovery in tort is permitted in cases [such as this

one] where the tort was committed after the termination of the

parties’ contract.”        
Id. at 177
(Traxler, C.J.).

      In a separate opinion, Judge Niemeyer explained that the

actions Bocek alleged, if proven at trial, would “give rise to a

classic claim for breach of the duty of loyalty inherent in the

agency agreement that existed between Bocek and JGA.”                     
Id. at 179
  (Niemeyer,    J.,    concurring    in    part    and   concurring   in   the

judgment).      Judge Niemeyer also concluded that “[t]he fact that

JGA terminated the agency agreement before taking advantage of

the opportunity that came to it while it was an agent provides

no defense.”       
Id. at 179
-80 (Niemeyer, J., concurring in part

and concurring in the judgment). 1


      1
          In   dissent,  Judge  Wilkinson   reasoned  that   the
defendants’ duty to refrain from using Bocek’s information arose
contractually, and thus that the defendants’ use of the
information they acquired from Bocek and on his behalf did not
give rise to a viable tort claim.     See Bocek v. JGA Assocs.,
(Continued)
                                        12
       On   remand,     following   a    bench    trial,    the    district    court

granted judgment to the defendants.                For reasons that we will

discuss, the district court ruled that Bocek did not prove that

the defendants had an agency relationship with him such that

fiduciary obligations would arise and that, even if they had

breached fiduciary duties owed to Bocek, Bocek failed to prove

damages from any breach.

                                         II.

       On appeal, Bocek challenges both the ruling that Amato was

not acting as Bocek’s agent with regard to the possible purchase

of ACC and the ruling that Bocek failed to prove any damages

even   if   he    did   prove   that    the    defendants   breached       fiduciary

duties they owed to him.         We consider these rulings seriatim.

                                         A.

       We begin by addressing the district court’s analysis of the

agency issue.          The district court stated that “[i]n seeking to

demonstrate an agency relationship, Bocek seemingly attempts to

implicate        two    different      ‘agreements’:         (1)     the     written

Consulting Agreement; and (2) an oral straw-purchase agreement

for the purchase of Allergy Care Centers.”                 J.A. 654.       The court

determined that the written agreement did not demonstrate that



LLC, 537 F. App’x 169, 180-82 (4th Cir. 2013) (Wilkinson, J.,
concurring and dissenting).



                                         13
the defendants agreed to act as Bocek’s agent to purchase the

ACC   because      that    agreement         provided     for     JGA’s     services    in

conjunction with a new, not an existing, medical practice.                             And,

regarding a possible oral agency agreement, the district court

noted that there was no meeting of the minds between the parties

such as would be necessary to create a binding contract for the

defendants to make a straw purchase of ACC.                        The district court

observed    that     while      the    parties      had       discussed   a   number    of

options of how such a purchase might be accomplished, they had

not agreed upon any particular method, and thus they had formed

only a nonbinding agreement to agree regarding a straw purchase.

For both of these reasons, the district court concluded that

“Bocek     did    not     carry       his     burden     to     establish     an   agency

relationship between himself and JGA or Amato, and therefore he

fail[ed] to establish that JGA or Amato owed him a fiduciary

obligation.”       J.A. 660.

      On   appeal,      Bocek     does      not    specifically       challenge     either

premise of the district court’s conclusion that he failed to

establish the agency relationship.                     Rather, Bocek’s position is

that the district court erred in concluding that, in attempting

to demonstrate the agency relationship, he relied only on the

existence    of     the    written          agreement     and    on   a   binding      oral

contract for Amato to purchase ACC on Bocek’s behalf.                               Bocek

maintains that the parties’ conduct after they entered into the

                                              14
written       agreement      clearly    demonstrated       the    existence    of    the

agency relationship. 2          And Bocek claims that he was not required

to show the formation of an oral agency contract in order to

show       that   Amato    actually    became     Bocek’s       agent   regarding    the

possible purchase.            Rather, Bocek maintains he needed only to

show       that   the     parties    each   consented      to    Amato’s    acting   on

Bocek’s behalf and under his control with regard to the efforts

to   purchase      ACC.       Bocek    contends     that    he    clearly   made    that

showing based on the undisputed facts proven at trial.                        We agree

with Bocek on all of these points.

       On consideration of an appeal following a bench trial, we

review the district court’s factual findings for clear error and

its legal conclusions de novo.                   See Universal Furniture Int’l,

Inc. v. Collezione Europa USA, Inc., 
618 F.3d 417
, 427 (4th Cir.

2010) (per        curiam).       A    factual    finding    is    clearly   erroneous

“when although there is evidence to support it, the reviewing

court on the entire evidence is left with the definite and firm


       2
          Indeed,   the  proposed   conclusions  of   law  Bocek
submitted to the district court following the trial included the
legal conclusion that “The Defendants were Bocek’s agents for
purposes of acquiring ACC.     Extensive email exchanges between
Dr. Bocek and Mr. Amato establish that Amato undertook steps
toward the purchase of ACC on behalf of, and at the direction
of, Bocek.    JGA’s billing for these services to Dr. Bocek
confirm the relationship.”     Plaintiff’s Proposed Findings of
Fact and Conclusions of Law 13-14, Docket No. 206, Civil Action
No. 1:11-cv-00546 (E.D. Va. Dec. 16, 2013).



                                            15
conviction that a mistake has been committed.”               United States v.

United States Gypsum Co., 
333 U.S. 364
, 395 (1948).

     In     Virginia,     “[a]gency     is      a   fiduciary     relationship

resulting from one person’s manifestation of consent to another

person that the other shall act on his behalf and subject to his

control, and the other person’s manifestation of consent so to

act.”     Reistroffer v. Person, 
439 S.E.2d 376
, 378 (Va. 1994).

Such a fiduciary relationship is found when “special confidence

has been reposed in one who in equity and good conscience is

bound to act in good faith and with due regard for the interests

of the one reposing the confidence.”            H-B Ltd. P’ship v. Wimmer,

257 S.E.2d 770
, 773 (Va. 1979).             Regarding the right to control,

“direct evidence is not indispensable – indeed frequently is not

available – but instead circumstances may be relied on, such as

the relation of the parties to each other and their conduct with

reference to the subject matter of the contract.”                     Acordia of

Va. Ins. Agency v. Genito Glenn, L.P., 
560 S.E.2d 246
, 250 (Va.

2002)       (alteration       and       internal        quotation          marks

omitted); see Royal Indem. Co. v. Hook, 
157 S.E. 414
, 419 (Va.

1931)     (“Frequently     [agency]     is     established      and    has,   of

necessity,    to   be    established    by     circumstantial     evidence.”).

“Agency may be inferred from the conduct of the parties and from

the surrounding facts and circumstances.”             Drake v. Livesay, 
341 S.E.2d 186
, 189 (Va. 1986).            “Whether an agency relationship

                                       16
exists is a question to be resolved by the fact finder unless

the existence of the relationship is shown by undisputed facts

or    by   unambiguous           written   documents.”           Acordia    of     Va.    Ins.

Agency, 560 S.E.2d at 250
(alteration and internal quotation

marks omitted); see also Schwartz v. Brownlee, 
482 S.E.2d 827
,

829 (Va. 1997) (explaining that “[w]hen there is no substantial

conflict       in        the     facts   and     circumstances         disclosed    by    the

evidence, it becomes a question of law to be decided by the

court whether one party was the agent of another” (alterations

and internal quotation marks omitted)).

       There can be no doubt as to the existence of an agency

relationship after the point that the parties entered into the

Consulting Agreement.                At that point, Bocek was paying JGA for

Amato’s services.                 Amato himself conceded that he understood

that, at least initially, “what [he was] to be doing, [he would

be]    doing        it     for     Dr.   Bocek”       and    “acting     subject    to    his

instructions and his directions.”                      J.A. 88.        And, the agreement

plainly established JGA’s authority to act as his agent with

regard to the lenders from whom Bocek sought financing.

       It is certainly true, as the district court observed, that

the    parties       entered        into   the    Consulting       Agreement       with   the

intention      that        JGA     would   provide          services    relating    to    the

formation of a new medical practice.                          However, five days after

entering into that agreement, Bocek raised the possibility that

                                                 17
he might purchase ACC or that Amato might advise him or assist

him in so doing.              Amato immediately undertook to help Bocek

determine the feasibility of the idea, including communicating

with    the     trustee      responsible          for    the       sale   and    obtaining

information      about    ACC’s      assets       on    Bocek’s      behalf.     The      only

conclusion to be drawn from the record is that the parties both

assented to JGA’s acting as Bocek’s agent in their dealings with

the    Estate    selling       ACC    just    as       they    had    contemplated        JGA

representing Bocek to possible lenders.

       Indeed, Amato himself testified that, at least initially,

he    was   “doing     the    due    diligence         work    regarding       ACC   at   Dr.

Bocek’s request” pursuant to their agreement “to help [Bocek]

with the medical practice.”                  J.A. 104-05.            See also J.A. 221

(language in Consulting Agreement stating that JGA, in addition

to the services specified in the agreement, would “render such

other services as may be agreed upon by” Bocek and JGA).                             And it

is undisputed that Amato reported to Bocek regularly regarding

his progress and billed Bocek for work regarding the possible

purchase of ACC.             It is also undisputed – and unsurprising –

that Bocek continued to provide instruction to Amato regarding

the    work     that   Amato     was    performing            on   his    behalf.         That

instruction included Bocek’s directive that Amato not disclose

his identity in the course of Amato’s communications with ACC.



                                             18
     When the defendants shifted toward actually negotiating for

the purchase of ACC, the parties’ communications and conduct

continued       to     point    unmistakably       toward    the        conclusion         that

Amato’s actions with regard to that purchase were made in the

context of the parties’ established plan for Amato to act on

Bocek’s       behalf    to     obtain   the    practice     for    Bocek.            Although

possible       issues     regarding      Bocek’s     ability       to    come        up    with

sufficient      capital        complicated     the   question      of     how    the       deal

would    be    structured,       the    parties’     communications         and       conduct

unmistakably         demonstrated       that   their      work,    including          Amato’s

placing of a closed bid to purchase ACC, continued to be part of

the defendants’ efforts on Bocek’s behalf to obtain the practice

for Bocek, as the parties’ emails of December 23, 27, and 28,

2010, plainly reflect.

     The only reasonable inference that can be drawn from all of

these facts, none of which are in dispute, is that Amato and

Bocek, by their conduct and communications with each other, both

assented to Amato’s acting on Bocek’s behalf and subject to his

control in helping Bocek evaluate the feasibility of purchasing

ACC and in working toward actually obtaining the practice for

Bocek.     And this fact, in turn, establishes the legal conclusion

that Amato was acting as Bocek’s agent.

     The district court’s analysis notwithstanding, there was no

reason     that      Bocek      was     required     to     show    that        an        agency

                                              19
relationship was established by a separate contract in order to

show that the parties both assented by their conduct to Amato’s

acting        as         Bocek’s        agent        regarding       Bocek’s          possible

purchase.          Cf. Bloxom v. Rose, 
144 S.E. 642
, 644 (Va. 1928)

(concluding that evidence was sufficient to support finding of

agency even though facts did not suggest that the parties had

agreed to any specific contractual terms).                                That the parties

never reached a meeting of the minds as to the manner in which

ACC would ultimately be transferred to Bocek simply does not

bear on the question of whether the parties had both assented to

the agency relationship.

     Moreover,           the     undisputed      facts      proven      at    trial    clearly

demonstrate         that       this    situation       is    one     in      which    “special

confidence         has    been     reposed      in    one   who    in     equity      and   good

conscience is bound to act in good faith and with due regard for

the interests of the one reposing the confidence.”                                    H-B Ltd.

P’ship, 257 S.E.2d at 773
.                   Bocek paid JGA – and JGA accepted

payment – for Amato’s expertise and assistance in determining

the worth of a business opportunity that Bocek had identified

for Amato for that purpose.                  Under such facts, the law precludes

Amato    in    equity       and       good   conscience      from       appropriating        the

opportunity        for     himself      once     he   determined        that    it     in   fact

carried with it the very potential for substantial profit that

Bocek had hoped it would.                       See Bocek, 537 F. App’x at 176-

                                                20
77; 
id. at 180
(Niemeyer, J., concurring in part and concurring

in the judgment) (“The law would be a buffoon if it allowed JGA

to   take   Bocek’s         opportunity    simply       by     ending    the     agency

relationship and proceeding thereafter in furtherance of its own

interest.”).

     The defendants take the position that at some point after

their    initial     work    regarding    the     ACC       purchase,    they    ceased

acting on Bocek’s behalf.          However, as we explained in our prior

opinion,    once     the    defendants’        duty    of   loyalty     toward    Bocek

arose, they could not extinguish it simply by terminating the

agency relationship.           See Bocek, 537 F. App’x at 177 (Traxler,

C.J.);   
id. at 179-80
   (Niemeyer,       J.,    concurring      in   part   and

concurring in the judgment).

     For all of these reasons, we hold as a matter of law that

Bocek    proved      that    the   defendants         breached    their      fiduciary

obligations to Bocek by appropriating the ACC opportunity for

themselves. 3      In so doing, we certainly acknowledge the district


     3
          In the prior appeal, Bocek appealed the grant of
summary judgment against him, and we determined that the facts
alleged, if proven at trial, would establish that the defendants
breached their fiduciary obligations to Bocek.      We were not
called upon to decide whether the evidence was sufficiently one-
sided that Bocek would have been entitled to summary judgment on
that issue had he sought it. See Appellees’ brief at 27 (noting
“the dissimilar postures between the First Appeal and the
instant appeal” in that the facts that Bocek claims he proved at
trial were “mere allegations” in the prior appeal).



                                          21
court’s role as the trier of fact as well as the deference we

must    afford    the    district      court’s       factual   findings.         But    the

material       facts    regarding      the    parties’    conduct       are   undisputed

(and     the     facts    regarding       the      parties’      secret,      subjective

intentions are immaterial to the agency issue).                          Whether those

undisputed facts establish the agency relationship is a legal

question for us to decide, see Acordia of Va. Ins. 
Agency, 560 S.E.2d at 250
,    and    for    the    reasons     we   have     explained,       we

conclude that they did establish the agency relationship.

                                              B.

       Bocek     also     argues      that     the     district    court        erred   in

concluding that even assuming that the defendants’ appropriation

for themselves of the ACC opportunity constituted a breach of

their fiduciary obligations to Bocek, Bocek failed to prove any

damages from the breach.              We agree.

       In Bocek’s Amended Complaint regarding this cause of action

he requested, among other remedies, money damages in the amounts

of “the difference between the purchase amount set forth in the

Asset Purchase Agreement and the true value of ACC’s assets on

[the]     date     of    the    Asset        Purchase    Agreement        or,    in     the

alternative, at the time that JGA transferred or assigned its

rights in the Asset Purchase Agreement to A2.”                      Verified Amended

Complaint       33,    Docket   No.     66,    Civil    Action    No.    1:11-cv-00546

(E.D. Va. July 22, 2011).               He also requested the “profits that

                                              22
Bocek would have derived as the owner of ACC’s assets . . . for

such period of time in the future as can be calculated to a

reasonable degree of probability.”                  
Id. To recover
damages for lost profits, a plaintiff “ha[s] the

burden    of    proving       with    reasonable          certainty     the    amount       of

damages and the cause from which they resulted; speculation and

conjecture cannot form the basis of the recovery.”                                 Banks v.

Mario    Indus.      of    Va.,   Inc.,      
650 S.E.2d 687
,    696    (Va.    2007)

(internal quotation marks omitted).

      Bocek testified that when he left ACC, he was earning a

salary of $450,000 per year and that the practice would have

paid him at least that amount in annual salary had he returned

as an owner.         He also testified that that salary was within the

range that a doctor with Bocek’s research experience and years

of practice would be expected to earn.                     He testified that having

started a new medical practice in 2011 when he was not able to

purchase    ACC’s      assets,       he   had     not   yet   been     able    to    turn    a

profit, but that he hoped to break even with the new business by

2015 and proceed from there.

      Bocek     also       presented      the      report     of      Certified      Public

Accountant Joseph S. Estabrook, who serves as a consultant in

the     areas   of        business    valuation,          litigation,        and    dispute

resolution.       Examining          ACC’s   financial        documents       through   May

2011, Estabrook conducted a detailed analysis and projected the

                                             23
practice’s net income would steadily increase from $478,271 in

2012 to $559,509 in 2016.                 Based on this and other factors,

Estabrook determined that ACC’s fair market value as of June 22,

2011, was $2,232,000. 4

        On the other hand, Amato testified that although ACC had

been profitable in the past, under A2’s ownership, the practice

was not profitable in the tax years 2011 and 2012.                      He testified

that on A2’s 2011 tax return, “after taking into consideration .

.   .       interest,     taxes,   depreciation,        and    amortization,”        A2

reported a loss of about $2,000.                J.A. 67.      Amato also testified

that near the end of 2011 an insurance audit revealed that the

billing practices of the prior management were inconsistent with

what the insurance companies required.                  He testified that “there

was going to be a drop of as much as 40 percent of top-line

revenue       because     [A2]   sought    to   bring    in    proper      billing   as

opposed       to   what   was    done   previously.”          J.A.   68.      And,   he

testified that A2 reported a loss of about $152,000 on its 2012

tax return.




        4
          Although A2 actually purchased ACC’s assets for
$1,000,000, Estabrook opined that “due to the financial
difficulties experienced by the Valentine Estate, coupled with
the fact that the Estate apparently did not employ traditional
marketing and sales efforts to maximize the sales price of the
practice, the offers and ultimate sales price for the practice
was substantially and artificially depressed.” J.A. 365.


                                           24
       Addressing the damages issue, the district court concluded

(1) that the direct and proximate cause of Bocek’s failure to

collect an income or prospective profits was Bocek’s termination

from ACC and the conduct that precipitated it, and (2) that A2

had not earned any profits since purchasing ACC that Bocek would

have earned had he purchased the business.            Regarding the second

point, the district court referenced the tax losses A2 reported

for 2011 and 2012.

       We conclude that neither of these reasons supported the

conclusion that Bocek had failed to prove damages.                 First of

all, whether Bocek was to blame for being terminated from his

position   at   ACC   simply    has    no   bearing   whatsoever    on   his

entitlement to damages.        Regardless of whether he harmed himself

financially by taking actions that brought about his termination

at ACC, any such conduct occurred prior to his dealings with

JGA.    Bocek sought to prove that purchasing ACC’s assets was an

opportunity for him to turn his financial fortunes around and

that the defendants harmed him by appropriating that opportunity

for themselves.

       Additionally, the fact that A2 reported losses on its 2011

and 2012 tax returns also does not show that Bocek would not

have profited in those years from his purchase of ACC’s assets.

First, even assuming arguendo that the practice’s revenues did

not exceed its expenses in those years, there was no evidence

                                      25
that the practice was not able to pay its expenses, including

doctor      salaries.        And     one   would     certainly     expect     that    the

reintroduction of Bocek to the practice would have reduced the

practice’s salary expenses for other physicians, increased its

ability to generate revenue, or both.                       In this regard, Bocek

testified that when he was working with ACC, he “carried 40

percent of the load of the practice because [he] was the only

board-certified allergist and the only full-time doctor.”                            J.A.

175.       Accordingly, the fact that A2 reported tax losses without

Bocek does not undercut Bocek’s claim that had he been back at

ACC practicing medicine, the practice would have generated the

revenue necessary to at least provide him with the income to

which he was accustomed. 5

       In    light    of     these    problems      with    the    district    court’s

analysis,      we    conclude      that    its    finding   that   Bocek    failed     to

prove      damages    from    the    defendants’       alleged     breach     of   their

fiduciary obligations was clearly erroneous and cannot serve as

a   basis      for     affirming       the       judgment    in    the     defendants’




       5
          Moreover, Amato himself conceded that the calculation
of A2’s tax losses included “paper losses” such as amortization
and   depreciation  that  offset  revenue   that  the  business
generated. And, Amato conceded that he drew $75,000 from A2 as
salary in 2011.



                                             26
favor. 6         See Wileman v. Frank, 
979 F.2d 30
, 38 (4th Cir. 1992)

(“In       the    unusual      case    where    the     district        court[’s]   .    .    .

reasoning         from     the    evidence      adduced       is    so     flawed   as       to

constitute         clear      error,   we,     as   a   court      of    appeals,   have      a

responsibility to correct that error.).                         We therefore reverse

the judgment in favor of the defendants and remand for entry of

judgment in favor of Bocek on the issue of liability and for a

new    trial       on   the    issue    of   what,      if   any,   remedies    Bocek        is

entitled to as a result of the defendants’ breach. 7


       6
          The defendants maintain that Bocek’s damages theories
that involve him returning to practice at ACC do not account for
the facts that (1) “he was prohibited from trespassing on the
four ACC locations in Maryland – pursuant to non-trespassing
orders issued by the Montgomery County, Maryland Department of
Police,” and (2) the entity that owned ACC could face liability
if it hired him with knowledge of his prior history. Appellees’
Brief at 32. However, there was no basis for concluding that if
Bocek owned or partly owned the practice, he still would have
been prohibited from entering ACC’s premises. There is likewise
no evidence suggesting that fear of negligent hiring liability
would have affected Bocek’s decisions regarding what role he
would assume.
       7
          We offer no view regarding Bocek’s entitlement to any
remedy he has requested, including the imposition of a
constructive trust.

     We note that Bocek requests that this case be assigned to a
different district court judge on remand.     We have previously
reviewed such requests by employing a three-factor test:

       (1) whether the original judge would reasonably be
       expected upon remand to have substantial difficulty in
       putting out of his or her mind previously expressed
       views or findings determined to be erroneous or based
       on evidence that must be rejected,

(Continued)
                                               27
                              III.

     For the foregoing reasons, we reverse the judgment in favor

of the defendants and remand for entry of judgment in favor of

Bocek on the issue of liability and for a new trial on the issue

of what, if any, remedies Bocek is entitled to in light of the

defendants’ breach of their fiduciary obligations to him.



                                            REVERSED AND REMANDED




     (2) whether reassignment is advisable to preserve the
     appearance of justice, and

     (3) whether reassignment would entail waste and
     duplication   out  of   proportion  to any gain in
     preserving the appearance of fairness.

United States v. Guglielmi, 
929 F.2d 1001
, 1007 (4th Cir. 1991)
(quoting United States v. Robin, 
553 F.2d 8
, 10 (2d Cir. 1977)).
Having considered these factors, we conclude that reassignment
would not be appropriate here.



                               28
WILKINSON, Circuit Judge, concurring:

     The reasoning in my earlier dissent, Bocek v. JGA Assocs.,

LLC, 537 F. App’x 169, 180-82 (4th Cir. 2013) (Wilkinson, J.,

concurring and dissenting), now being precluded by the law of

the case, I concur in the majority’s opinion.




                               29

Source:  CourtListener

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer